contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.


中文版 >>

China National Health Development Research Center (CNHDRC)

The China National Health Development Research Center, or CNHDRC, (formerly known as the China Health Economics Institute), is a research institution based in Beijing and established in 1991 under the leadership of the Chinese Ministry of Health (MoH). It operates as a national think tank providing technical consultancy to health policy makers across the country. Over the last two decades CNHDRC has grown significantly; the institution currently hosts 82 registered researchers, 25 contract-based or temporarily-deployed research fellows, and eight internationally-famous scholars as chief experts or invited research fellows.



  1. Conduct research on health development and reform strategy and take part in health development and reform programs;
  2. Conduct research on public health policy and provide health policy-makers with policy recommendations;
  3. Conduct health management research and implement relevant programs;
  4. Conduct research and programs on health policy and health technology evaluation;
  5. Conduct research on health economics and health management theories and methodologies and implement relevant programs.

Who we work with at CNHDRC

  • Prof. Zhang Zhenzhong, FHS China General Superintendent (FHS Publications)
  • Prof. Mao Zhengzhong, FHS China Chief Technical Director
  • Main researchers:

Recent FHS publications involving CNHDRC


This paper analyses the main policy documents of Urban Employee Basic Medical Insurance System (UEBMIS) over the past two decades and the institutional environment, experiences, and problems in the process of reform. The authors state that in the future, UEBMIS should proceed according to the guideline of ensuring basic demands, establishing a multi-level security system, and ensuring sustainability. It should also proceed according to the guideline of gradual advancement and piloting first. Top-level design and linkage reform should be improved, national data should be unified, and a data-evaluation system should be established.

Through summarizing the new situation and new problems since the pilot implementation development of urban and rural medical insurance for catastrophic diseases in China, this article analyzes the nature of medical insurance for catastrophic diseases and the relationship among New Rural Cooperative Medical System and Basic Medical Insurance for urban residents, puts forward the main difficulties and the faced challenges in the development of medical insurance for catastrophic diseases.

Establishment of medical security and assistance mechanisms for catastrophic diseases is the focus of health care reform to tackle the large medical expense burden. Based on sorting out the stage of the development of China's severe illness security policy, point out the cotent and difficulties of the connection of medical assistance and medical insurance for catastrophic diseases, analyse the main problems of medical assistance for catastrophic diseases and give appropriate policy recommendations.

This journal article aims to evaluate the impact of the global budget on health care costs of one pilot hospital by comparatively analyzing the data before and after the policy implementation, and then put forward proposals and suggestion for the improvement of the policy. 

There is growing international concern about the threat to public health of the emergence and spread of bacteria resistant to existing antibiotics. An effective response must invest in both the development of new drugs and measures to slow the emergence of resistance. This paper addresses the former. It focuses on low and middle-income countries with pluralistic health systems, where people obtain much of their antibiotics in unorganised markets. 

In 2009 the government of China identified an essential drugs policy as one of five priority areas for health system reform. Since then, a national essential drugs policy has been defined, along with plans to implement it. As a large scale social intervention, the policy will have a significant impact on various local health actors. This paper uses the lens of complex adaptive systems to examine how the policy has been implemented in three rural Chinese counties. Using material gathered from interviews with key actors in county health bureaus and township health centers, we illustrate how a single policy can lead to multiple unanticipated outcomes. The complexity lens applied to the material gathered in interviews helps to identify relevant actors, their different relationships and policy responses and a new framework to better understand heterogeneous pathways and outcomes. Decision-makers and policy implementers are advised to embrace the complex and dynamic realities of policy implementation. This involves developing mechanisms to monitor different behaviors of key actors as well as the intended outcomes and unintended consequences of the policy.